<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia - Badawy, SM - 2019 | Cochrane Library</title> <meta content="Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia - Badawy, SM - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012900.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia - Badawy, SM - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012900.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012900.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia" name="citation_title"/> <meta content="Sherif M Badawy" name="citation_author"/> <meta content="Ann &amp; Robert H. Lurie Children’s Hospital of Chicago" name="citation_author_institution"/> <meta content="SBadawy@luriechildrens.org" name="citation_author_email"/> <meta content="Kerry Morrone" name="citation_author"/> <meta content=" Northwestern University Feinberg School of Medicine" name="citation_author_institution"/> <meta content="Alexis Thompson" name="citation_author"/> <meta content="Children's Hospital at Montefiore" name="citation_author_institution"/> <meta content="Tonya M Palermo" name="citation_author"/> <meta content="Ann &amp; Robert H. Lurie Children’s Hospital of Chicago" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD012900.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/06/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012900.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012900.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012900.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Age Factors; *Cell Phone; *Chelation Therapy; Disease Management; Iron Overload [*drug therapy]; *Medication Adherence; Thalassemia [*therapy]; *Therapy, Computer-Assisted" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012900.pub2&amp;doi=10.1002/14651858.CD012900.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="7LavyS58";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012900\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012900\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","de","ru","ja","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012900.pub2",title:"Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia",firstPublishedDate:"Jun 28, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012900.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012900.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012900.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012900.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012900.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012900.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012900.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012900.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012900.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012900.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2364 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012900.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-sec-0098"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-sec-0084"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-sec-0092"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/appendices#CD012900-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#CD012900-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sherif M Badawy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#CD012900-cr-0003">Kerry Morrone</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#CD012900-cr-0004">Alexis Thompson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information#CD012900-cr-0005">Tonya M Palermo</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information/en#CD012900-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 June 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012900.pub2">https://doi.org/10.1002/14651858.CD012900.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012900-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012900-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012900-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012900-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012900-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012900-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012900-abs-0001" lang="en"> <section id="CD012900-sec-0001"> <h3 class="title" id="CD012900-sec-0001">Background</h3> <p>Thalassemia syndromes are inherited hemoglobin disorders that result when the synthesis of normal hemoglobin is lacking or significantly reduced. For people with thalassemia, long‐term red blood cell transfusion remains the mainstay of therapy, which may lead to iron overload causing severe complications and damage in different body organs. Long‐term iron chelation therapy is essential for people with thalassemia to minimize the ongoing iron‐loading process. In addition, suboptimal adherence can increase adverse events associated with iron overload and result in increased morbidity, mortality, healthcare utilization and cost of care. </p> </section> <section id="CD012900-sec-0002"> <h3 class="title" id="CD012900-sec-0002">Objectives</h3> <p>To identify and assess the effects of computer and mobile technology interventions designed to facilitate medication adherence and disease management in individuals with thalassemia, including: </p> <p>‐ evaluating the effects of using computer and mobile technology interventions for medication adherence and disease management on health and behavioral outcomes; </p> <p>‐ identifying and assessing the effects of computer and mobile technology interventions specific to different age groups (children, adolescents and adults) and type of modality (e.g. cell phone, the Internet). </p> </section> <section id="CD012900-sec-0003"> <h3 class="title" id="CD012900-sec-0003">Search methods</h3> <p>We searched CENTRAL (the Cochrane Library), MEDLINE, Embase, CINAHL, PsycINFO, ProQuest Dissertations &amp; Theses Global, Psychology and Behavioral Sciences Collection, Web of Science Science &amp; Social Sciences Conference Proceedings Indexes, IEEE Xplore and ongoing trial databases (22 February 2018). We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group’s Haemoglobinopathies Trials Register (20 June 2019). We also searched for unpublished work in the abstract book of nine major conferences in the related field. </p> </section> <section id="CD012900-sec-0004"> <h3 class="title" id="CD012900-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCT) and quasi‐RCTs comparing single‐ or multi‐component interventions versus no intervention, placebo or standard care, with adherence to iron chelation as the primary outcome were eligible for inclusion. Non‐randomized studies of interventions, controlled before‐after studies, and interrupted‐time‐series studies were also eligible for inclusion. </p> </section> <section id="CD012900-sec-0005"> <h3 class="title" id="CD012900-sec-0005">Data collection and analysis</h3> <p>Three authors independently assessed study eligibility. If we had included any studies, we would have independently assessed risk of bias and extracted data; we planned to assess the quality of the evidence using GRADE. </p> </section> <section id="CD012900-sec-0006"> <h3 class="title" id="CD012900-sec-0006">Main results</h3> <p>We did not identify any eligible studies for inclusion in the review.</p> </section> <section id="CD012900-sec-0007"> <h3 class="title" id="CD012900-sec-0007">Authors' conclusions</h3> <p>Due to lack of evidence, we cannot comment on the efficacy or effectiveness of computer and mobile technology intervention strategies to promote disease management and adherence to iron chelation therapy in people with thalassemia. </p> <p>We concluded that RCTs are needed to examine a variety of computer and mobile technology intervention strategies that may be useful for promoting disease management and increasing adherence to iron chelation therapy in individuals with thalassemia. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012900-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012900-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012900-abs-0010">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012900-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012900-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012900-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012900-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012900-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012900-abs-0011">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012900-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012900-abs-0005" lang="en"> <h3>Strategies to improve disease management and increase adherence to iron chelation therapy in people with thalassaemia </h3> <p><b>Review question</b> </p> <p>We wanted to see if there were any interventions using computer and mobile technology (e.g. cell phone, the Internet) that would help people manage their thalassemia better and adhere more to their iron chelation therapy. </p> <p><b>Background</b> </p> <p>People with thalassaemia, who receive regular transfusions, are exposed to excess iron in their body. This can result in medical complications, including organ damage and death. Some medications are used to remove excess iron in the body, but these treatment schedules can be difficult to follow and have undesirable side effects. </p> <p><b>Search date</b> </p> <p>The evidence is current to 20 June 2019.</p> <p><b>Study characteristics</b> </p> <p>We searched the literature for both randomized and non‐randomized studies, and found none which were eligible for inclusion. </p> <p><b>Key results</b> </p> <p>We found no eligible studies of computer and mobile technology intervention strategies for individuals with thalassemia. </p> <p><b>Quality of evidence</b> </p> <p>We did not identify any evidence for inclusion in the review.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012900-sec-0098" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012900-sec-0098"></div> <h3 class="title" id="CD012900-sec-0099">Implications for practice</h3> <section id="CD012900-sec-0099"> <p>Optimal disease management and adherence to iron chelation regimens can reduce morbidity and mortality in people with thalassaemia. Iron chelation regimens are not without side effects, which could reduce adherence levels. Evidence from other systematic reviews have identified several effective intervention strategies for promoting disease management and medication adherence, particularly in people with chronic medical conditions. In this review, we did not identify any randomized controlled trials (RCTs), cluster‐RCTs, controlled before‐after studies or interrupted‐time‐series studies that met the inclusion criteria. Therefore, well‐designed clinical trials are needed to evaluate the successful translation of these intervention strategies to iron chelation regimens and disease management in this population. </p> </section> <h3 class="title" id="CD012900-sec-0100">Implications for research</h3> <section id="CD012900-sec-0100"> <p>Due to lack of evidence, we cannot comment on the efficacy or effectiveness of computer and mobile technology intervention strategies to promote disease management and adherence to iron chelation therapy in people with thalassemia. This limited evidence suggests that investigators need to be encouraged to develop and evaluate mobile technology interventions using various early‐phase behavioral intervention study designs with small available samples. For example, rigorous single‐study designs, mixed‐methods designs, fidelity, and pilot‐feasibility studies would help to optimize intervention development and pave the way for later efficacy studies (<a href="./references#CD012900-bbs2-0041" title="CzajkowskiSM , PowellLH , AdlerN , Naar‐KingS , ReynoldsKD , HunterCM , et al. From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Health Psychology2015;34(10):971‐82. ">Czajkowski 2015</a>). </p> <p>In the future, RCTs will be needed to examine the efficacy of these interventions for improving adherence rates and disease management in this population. In addition, high‐quality, non‐randomized studies of interventions that measure adherence to iron chelation therapy before and after an intervention, over multiple time points, or in multiple settings could help to identify evidence‐based strategies that promote disease management and adherence to iron chelation regimens in people with thalassemia. Additionally, multi‐modal assessment of adherence to iron chelation regimens using valid and reliable commonly used tools are essential to accurately assess the effects of an intervention, particularly in relation to quality of life, patient‐reported outcomes, other health outcomes, morbidity and mortality. Finally, targeted strategies for different age groups, especially adolescents, are warranted. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012900-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012900-sec-0029"></div> <section id="CD012900-sec-0030"> <h3 class="title" id="CD012900-sec-0030">Description of the condition</h3> <p>Thalassemia syndromes are inherited hemoglobin disorders that result when the synthesis of normal hemoglobin is lacking or significantly reduced (<a href="./references#CD012900-bbs2-0061" title="MartinA , ThompsonAA . Thalassemias. Pediatric Clinics of North America2013;60(6):1383‐91. ">Martin 2013</a>). Approximately 5% of the world's populations are estimated to carry one variant globin allele with over 300,000 newborns affected with the disease (i.e. thalassemia syndrome) every year (<a href="./references#CD012900-bbs2-0089" title="WeatherallDJ . The definition and epidemiology of non‐transfusion‐dependent thalassemia. Blood Reviews2012;26 Suppl 1:S3‐6. ">Weatherall 2012</a>). </p> <p>Thalassemia syndromes include either alpha (α) thalassemia or beta (β) thalassemia. α‐thalassemia is caused by either absent or decreased production of α‐globin chains and its clinical severity varies based on the number of alleles affected as well as the type of genetic mutation (<a href="./references#CD012900-bbs2-0053" title="HiggsDR , GibbonsRJ . The molecular basis of alpha‐thalassemia: a model for understanding human molecular genetics. Hematology/Oncology Clinics of North America2010;24(6):1033‐54. ">Higgs 2010</a>). β‐thalassemia is caused by either absent or decreased production of β‐globin chains and its clinical presentation can be as early as the first six months of life with moderate to severe anemia, or in early childhood with symptoms such as anemia, jaundice, abdominal distention, hepatosplenomegaly and poor growth (<a href="./references#CD012900-bbs2-0072" title="RundD , RachmilewitzE . Beta‐thalassemia. New England Journal of Medicine.2005;353(11):1135‐46. ">Rund 2005</a>). People with transfusion‐dependent thalassemia (TDT) require blood transfusions on a regular basis, on average 8 to 12 times or more per year. In contrast, those with non‐transfusion‐dependent thalassemia (NTDT) can maintain an adequate hemoglobin level and require packed red blood cell (RBC) transfusions only in times of physiologic stress, or fewer than eight times per year (<a href="./references#CD012900-bbs2-0061" title="MartinA , ThompsonAA . Thalassemias. Pediatric Clinics of North America2013;60(6):1383‐91. ">Martin 2013</a>; <a href="./references#CD012900-bbs2-0072" title="RundD , RachmilewitzE . Beta‐thalassemia. New England Journal of Medicine.2005;353(11):1135‐46. ">Rund 2005</a>). For people with thalassemia, stem cell transplantation is the only curative treatment option (<a href="./references#CD012900-bbs2-0024" title="AngelucciE . Hematopoietic stem cell transplantation in thalassemia. Hematology: The Education Program of the American Society of Hematology2010;1:456‐62. ">Angelucci 2010</a>) and long‐term RBC transfusion remains the mainstay of therapy, which may lead to iron overload causing severe complications and damage in different body organs (<a href="./references#CD012900-bbs2-0061" title="MartinA , ThompsonAA . Thalassemias. Pediatric Clinics of North America2013;60(6):1383‐91. ">Martin 2013</a>). </p> <p>Long‐term iron chelation is essential for people with thalassemia to minimize the ongoing iron loading process (<a href="./references#CD012900-bbs2-0069" title="RachmilewitzEA , GiardinaPJ . How I treat thalassemia. Blood2011;118(13):3479‐88. ">Rachmilewitz 2011</a>; <a href="./references#CD012900-bbs2-0088" title="WareHM , KwiatkowskiJL . Evaluation and treatment of transfusional iron overload in children. Pediatric Clinics of North America2013;60(6):1393‐406. ">Ware 2013</a>). Three iron‐chelating agents, deferoxamine, deferiprone, and deferasirox, are approved by the USA's Food &amp; Drug Administration (FDA) and are commercially available. Routine monitoring may vary with different iron chelators and as a minimum should include serum ferritin levels (every three months) and measurements of cardiac and liver iron burden with annual magnetic resonance imaging (MRI) scans (<a href="./references#CD012900-bbs2-0026" title="BadawySM , ThompsonAA . Management challenges in thalassemia. In: AbutalibSA , ConnorsJM , RagniMV editor(s). Nonmalignant Hematology, Expert Clinical Review: Questions and Answer. Springer International Publishing, Switzerland, 2016. ">Badawy 2016a</a>; <a href="./references#CD012900-bbs2-0061" title="MartinA , ThompsonAA . Thalassemias. Pediatric Clinics of North America2013;60(6):1383‐91. ">Martin 2013</a>). Recent studies have shown the need for iron chelation therapies has an impact on the quality of life of people with thalassemia and results in low levels of personal satisfaction (<a href="./references#CD012900-bbs2-0023" title="AbetzL , BaladiJF , JonesP , RofailD . The impact of iron overload and its treatment on quality of life: results from a literature review. Health and Quality of Life Outcomes2006;4:73. ">Abetz 2010</a>; <a href="./references#CD012900-bbs2-0036" title="CappelliniMD , BejaouiM , AgaogluL , PorterJ , CoatesT , JengM , et al. Prospective evaluation of patient‐reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta‐thalassemia. Clinical Therapeutics2007;29(5):909‐17. ">Cappellini 2007</a>; <a href="./references#CD012900-bbs2-0065" title="PayneKA , RofailD , BaladiJF , VialaM , AbetzL , DesrosiersMP , et al. Iron chelation therapy: clinical effectiveness, economic burden and quality of life in patients with iron overload. Advances in Therapy2008;25(8):725‐42. ">Payne 2008</a>; <a href="./references#CD012900-bbs2-0068" title="PorterJ , BowdenDK , EconomouM , TroncyJ , GanserA , HabrD , et al. Health‐related quality of life, treatment satisfaction, adherence and persistence in beta‐thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial. Anemia2012;2012:297641. ">Porter 2012</a>; <a href="./references#CD012900-bbs2-0080" title="TaherA , Al JefriA , ElalfyMS , Al ZirK , DaarS , RofailD , et al. Improved treatment satisfaction and convenience with deferasirox in iron‐overloaded patients with beta‐thalassemia: results from the ESCALATOR trial. Acta Haematologica2010;123(4):220‐5. ">Taher 2010</a>; <a href="./references#CD012900-bbs2-0083" title="TrachtenbergFL , MednickL , KwiatkowskiJL , NeufeldEJ , HainesD , PakbazZ , et al. Beliefs about chelation among thalassemia patients. Health and Quality of Life Outcomes2012;10:148. ">Trachtenberg 2012a</a>; <a href="./references#CD012900-bbs2-0084" title="TrachtenbergFL , GerstenbergerE , XuY , MednickL , SobotaA , WareH , et al. Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Quality of Life Research2014;23(8):2277‐88. ">Trachtenberg 2014</a>). In addition, suboptimal adherence can increase adverse events associated with iron overload and result in increased morbidity, mortality, healthcare utilization and cost of care (<a href="./references#CD012900-bbs2-0044" title="DiMatteoMR , GiordaniPJ , LepperHS , CroghanTW . Patient adherence and medical treatment outcomes: a meta‐analysis. Medical Care2002;40(9):794‐811. ">DiMatteo 2002</a>; <a href="./references#CD012900-bbs2-0073" title="SabateE . Adherence to long‐term therapies: evidence for action. www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed prior to 15 June 2017). ">Sabate 2003</a>; <a href="./references#CD012900-bbs2-0086" title="VekemanF , SasaneM , ChengWY , RamanakumarAV , FortierJ , QiuY , et al. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. Journal of Medical Economics2016;19(3):292‐303. ">Vekeman 2016</a>). </p> </section> <section id="CD012900-sec-0031"> <h3 class="title" id="CD012900-sec-0031">Description of the intervention</h3> <p>Mobile technology interventions for promoting medication adherence and disease management include delivery of education, reminders, or behavioral skills through cell (mobile) phones (e.g. text‐messaging and mobile applications), the Internet (e.g. web‐based interventions), or other mobile technology tools. Mobile technology interventions could: </p> <p> <ol id="CD012900-list-0001"> <li> <p>enhance the communication between patients and healthcare providers,</p> </li> <li> <p>facilitate management and self‐monitoring of thalassemia;</p> </li> <li> <p>provide education about thalassemia, iron chelators and other related medications;</p> </li> <li> <p>support adherence to iron chelators or medications using reminders;</p> </li> <li> <p>offer a network for communication among patients with thalassemia;</p> </li> <li> <p>support decision making for people with thalassemia and their parents or caregivers; or </p> </li> <li> <p>collect or capture users' data (from the individuals concerned and their parents or caregivers). </p> </li> </ol> </p> <p>We conducted a brief scoping review of the literature in PubMed and found two published studies that used mobile‐based interventions to improve adherence to iron chelation in people with thalassemia (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>; <a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). The first study included 35 people with thalassemia (aged 18 to 34 years), who were part of a Delphi process to inform the development of a mobile app to improve disease self‐management, including adherence to chelation therapy (<a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). The research team was able to develop and test the mobile app with participants who perceived it as highly favorable with improved adherence to iron chelation and positive experience using it, especially the adherence pledge functionality and customized treatment goals (<a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). The second study included 11 people (β‐thalassemia major and sickle cell anemia) receiving chronic blood transfusions and evaluated a mobile app intervention as part of an intensive training program to improve disease self‐management, including adherence to iron chelation therapy (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>). The authors reported on the feasibility of the mobile app intervention and that there was high acceptability and improved disease knowledge, as well as adherence to iron chelation therapy (using medication possession ration with pharmacy records and laboratory markers of adherence) with serum ferritin levels trending downwards (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>). </p> </section> <section id="CD012900-sec-0032"> <h3 class="title" id="CD012900-sec-0032">How the intervention might work</h3> <p>Mobile technology interventions for promoting medication adherence and disease management could: </p> <p> <ol id="CD012900-list-0002"> <li> <p>enhance an individual's self‐efficacy, organizational skills, or change adherence behavior (e.g. reminders for daily iron chelators, clinic appointment reminders, transfusion reminders, feedback on adherence to iron chelation therapy); </p> </li> <li> <p>provide a form of communication (e.g. health professionals);</p> </li> <li> <p>establish social support networks (e.g. advocacy groups, peer‐to‐peer networks); or</p> </li> <li> <p>provide education about thalassemia, iron chelation therapy and necessary steps for optimal disease management. </p> </li> </ol> </p> <p>By increasing self‐efficacy (<a href="./references#CD012900-bbs2-0034" title="BanduraA . Self‐efficacy: toward a unifying theory of behavioral change. Psychological Review1977;84(2):191‐215. ">Bandura 1977</a>) and providing support mechanisms (<a href="./references#CD012900-bbs2-0037" title="ChristakisNA . Social networks and collateral health effects. BMJ2004;329(7459):184‐5. ">Christakis 2004</a>; <a href="./references#CD012900-bbs2-0038" title="CobbS . Presidential Address‐1976. Social support as a moderator of life stress. Psychosomatic Medicine1976;38(5):300‐14. ">Cobb 1976</a>; <a href="./references#CD012900-bbs2-0039" title="CohenS , WillsTA . Stress, social support, and the buffering hypothesis. Psychological Bulletin1985;98(2):310‐57. ">Cohen 1985</a>), computer and mobile technology interventions may influence health behaviors and enhance self‐management of long‐term illnesses. These interventions may facilitate education on self‐management problem solving skills, and in this way increase the individual's confidence in carrying out the behaviors necessary to achieve the desired goal of optimum disease management. A recently developed taxonomy of behavior change techniques (BCT) has been published with 93 consensually agreed, distinct BCTs, which will help to further define specific intervention effects, including mobile technology interventions (<a href="./references#CD012900-bbs2-0062" title="MichieS , RichardsonM , JohnstonM , AbrahamC , FrancisJ , HardemanW , et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Annals of Behavioral Medicine2013;46(1):81‐95. ">Michie 2013</a>). </p> </section> <section id="CD012900-sec-0033"> <h3 class="title" id="CD012900-sec-0033">Why it is important to do this review</h3> <p>Management of thalassemia represents a challenge for people with the disease and their families (<a href="./references#CD012900-bbs2-0026" title="BadawySM , ThompsonAA . Management challenges in thalassemia. In: AbutalibSA , ConnorsJM , RagniMV editor(s). Nonmalignant Hematology, Expert Clinical Review: Questions and Answer. Springer International Publishing, Switzerland, 2016. ">Badawy 2016a</a>; <a href="./references#CD012900-bbs2-0046" title="EvangeliM , MughalK , PorterJB . Which psychosocial factors are related to chelation adherence in thalassemia? A systematic review. Hemoglobin2010;34(3):305‐21. ">Evangeli 2010</a>). Recent reports demonstrated a high prevalence of poor self‐management and non‐adherence in thalassemia in both children and adults (<a href="./references#CD012900-bbs2-0036" title="CappelliniMD , BejaouiM , AgaogluL , PorterJ , CoatesT , JengM , et al. Prospective evaluation of patient‐reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta‐thalassemia. Clinical Therapeutics2007;29(5):909‐17. ">Cappellini 2007</a>; <a href="./references#CD012900-bbs2-0046" title="EvangeliM , MughalK , PorterJB . Which psychosocial factors are related to chelation adherence in thalassemia? A systematic review. Hemoglobin2010;34(3):305‐21. ">Evangeli 2010</a>; <a href="./references#CD012900-bbs2-0048" title="HaghpanahS , ZareiT , ZahediZ , KarimiM . Compliance and satisfaction with deferasirox (Exjade(R)) compared with deferoxamine in patients with transfusion‐dependent beta‐thalassemia. Hematology2014;19(4):187‐91. ">Haghpanah 2014</a>; <a href="./references#CD012900-bbs2-0056" title="LeeWS , TohTH , ChaiPF , SooTL . Self‐reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias. Journal of Paediatrics and Child Health2011;47(8):535‐40. ">Lee 2011</a>; <a href="./references#CD012900-bbs2-0068" title="PorterJ , BowdenDK , EconomouM , TroncyJ , GanserA , HabrD , et al. Health‐related quality of life, treatment satisfaction, adherence and persistence in beta‐thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial. Anemia2012;2012:297641. ">Porter 2012</a>; <a href="./references#CD012900-bbs2-0067" title="PorterJB , EvangeliM , El‐BeshlawyA . Challenges of adherence and persistence with iron chelation therapy. International Journal of Hematology2011;94(5):453‐60. ">Porter 2011</a>; <a href="./references#CD012900-bbs2-0082" title="TrachtenbergF , VichinskyE , HainesD , PakbazZ , MednickL , SobotaA , et al. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. American Journal of Hematology2011;86(5):433‐6. ">Trachtenberg 2011</a>; <a href="./references#CD012900-bbs2-0086" title="VekemanF , SasaneM , ChengWY , RamanakumarAV , FortierJ , QiuY , et al. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. Journal of Medical Economics2016;19(3):292‐303. ">Vekeman 2016</a>) similar to other chronic health conditions (<a href="./references#CD012900-bbs2-0060" title="LoiselleK , LeeJL , SzulczewskiL , DrakeS , CrosbyLE , PaiAL . Systematic and meta‐analytic review: medication adherence among pediatric patients with sickle cell disease. Journal of Pediatric Psychology2016;41(4):406‐18. ">Loiselle 2016</a>; <a href="./references#CD012900-bbs2-0063" title="ModiAC , PaiAL , HommelKA , HoodKK , CortinaS , HilliardME , et al. Pediatric self‐management: a framework for research, practice, and policy. Pediatrics2012;129(2):e473‐85. ">Modi 2012</a>; <a href="./references#CD012900-bbs2-0087" title="WalshKE , CutronaSL , KavanaghPL , CrosbyLE , MaloneC , LobnerK , et al. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics2014;134(6):1175‐83. ">Walsh 2014</a>). Nevertheless, effective self‐management is essential to maximize treatment efficacy, optimize clinical outcomes, and reduce unnecessary health care utilization and costs (<a href="./references#CD012900-bbs2-0063" title="ModiAC , PaiAL , HommelKA , HoodKK , CortinaS , HilliardME , et al. Pediatric self‐management: a framework for research, practice, and policy. Pediatrics2012;129(2):e473‐85. ">Modi 2012</a>). However, people with thalassemia and their families are responsible for managing complex and time‐consuming treatment regimens, including daily medications (e.g. iron chelators, vitamins, hormonal supplements), laboratory monitoring (e.g. serum ferritin, hemoglobin concentration), imaging studies (e.g. MRI of liver R2*, MRI of heart T2*), and attendance at regular transfusions as well as routine clinic appointments with a variety of healthcare professionals (<a href="./references#CD012900-bbs2-0026" title="BadawySM , ThompsonAA . Management challenges in thalassemia. In: AbutalibSA , ConnorsJM , RagniMV editor(s). Nonmalignant Hematology, Expert Clinical Review: Questions and Answer. Springer International Publishing, Switzerland, 2016. ">Badawy 2016a</a>; <a href="./references#CD012900-bbs2-0069" title="RachmilewitzEA , GiardinaPJ . How I treat thalassemia. Blood2011;118(13):3479‐88. ">Rachmilewitz 2011</a>; <a href="./references#CD012900-bbs2-0072" title="RundD , RachmilewitzE . Beta‐thalassemia. New England Journal of Medicine.2005;353(11):1135‐46. ">Rund 2005</a>). These treatment regimens could place substantial burden on individuals with thalassemia and their families, and effective management of these regimens represents a challenge to them. Moreover, in relation to industrialised countries, given that thalassemia predominantly affects individuals who are of ethnic minorities (<a href="./references#CD012900-bbs2-0072" title="RundD , RachmilewitzE . Beta‐thalassemia. New England Journal of Medicine.2005;353(11):1135‐46. ">Rund 2005</a>; <a href="./references#CD012900-bbs2-0089" title="WeatherallDJ . The definition and epidemiology of non‐transfusion‐dependent thalassemia. Blood Reviews2012;26 Suppl 1:S3‐6. ">Weatherall 2012</a>), disparities in access to care and resources may also serve as further barriers to effective self‐management. </p> <p>People with thalassemia and their families have adopted computer and mobile technology such as standard cell phones, smartphones, the Internet, and social networking at a rapid rate across levels of social position and status (<a href="./references#CD012900-bbs2-0027" title="BadawySM , ThompsonAA , LiemRI . Technology access and smartphone app preferences for medication adherence in adolescents and young adults with sickle cell disease. Pediatric Blood &amp; Cancer2016;63(5):848‐52. ">Badawy 2016b</a>; <a href="./references#CD012900-bbs2-0057" title="Lenhart , A . Teens, Social Media &amp; Technology Overview 2015. www.pewinternet.org/2015/04/09/teens‐social‐media‐technology‐2015/ (accessed prior to 15 June 2017). ">Lenhart 2015</a>; <a href="./references#CD012900-bbs2-0075" title="ShahN , JonassaintJ , DeCastroL . Patients welcome the Sickle Cell Disease Mobile Application to Record Symptoms via Technology (SMART). Hemoglobin2014;38(2):99‐103. ">Shah 2014</a>; <a href="./references#CD012900-bbs2-0076" title="SmithA . U.S. smartphone use in 2015. www.pewinternet.org/2015/04/01/us‐smartphone‐use‐in‐2015/ (accessed prior to 15 June 2017). ">Smith 2015a</a>; <a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). Therefore, the widespread availability and frequent use of these technologies by those with thalassemia and their families across age groups present an opportunity to develop high‐quality, efficacious, and cost‐effective interventions to facilitate self‐management, promote medication adherence, link people with thalassemia with their physicians, and improve health outcomes (<a href="./references#CD012900-bbs2-0027" title="BadawySM , ThompsonAA , LiemRI . Technology access and smartphone app preferences for medication adherence in adolescents and young adults with sickle cell disease. Pediatric Blood &amp; Cancer2016;63(5):848‐52. ">Badawy 2016b</a>; <a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>; <a href="./references#CD012900-bbs2-0075" title="ShahN , JonassaintJ , DeCastroL . Patients welcome the Sickle Cell Disease Mobile Application to Record Symptoms via Technology (SMART). Hemoglobin2014;38(2):99‐103. ">Shah 2014</a>; <a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). There has been growing interest and evidence to support the utilization of technology‐based strategies, including mobile technology interventions, to improve medication adherence and self‐management in people with chronic health conditions (<a href="./references#CD012900-bbs2-0029" title="BadawySM , KuhnsLM . Texting and mobile phone app interventions for improving adherence to preventive behavior in adolescents: a systematic review. JMIR Mhealth and Uhealth2017;5(4):e50. ">Badawy 2017a</a>; <a href="./references#CD012900-bbs2-0030" title="BadawySM , SinnoMG , KavianyS , O’DwyerL , KuhnsLM . Text messaging and smartphone app interventions to improve medication adherence in adolescents with chronic conditions: a systematic review. JMIR Mhealth and Uhealth2017;5(5):e66. ">Badawy 2017b</a>; <a href="./references#CD012900-bbs2-0031" title="BadawySM , ThompsonAA , KuhnsLM . Medication Adherence and Technology‐Based Interventions for Adolescents With Chronic Health Conditions: A Few Key Considerations. JMIR Mhealth Uhealth2017;5(12):e202. ">Badawy 2017c</a>; <a href="./references#CD012900-bbs2-0032" title="BadawySM , CroninRM , HankinsJ , CrosbyL , DeBaunM , ThompsonAA , ShahN . Patient‐Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review. Journal of Medical Internet Research2018;20(7):e10940. ">Badawy 2018</a>; <a href="./references#CD012900-bbs2-0035" title="BonotoBC , deAraujoVE , GodoiIP , deLemosLL , GodmanB , BennieM , et al. Efficacy of mobile apps to support the care of patients with diabetes mellitus: a systematic review and meta‐analysis of randomized controlled trials. JMIR Mhealth and Uhealth2017;5(3):e4. ">Bonoto 2017</a>; <a href="./references#CD012900-bbs2-0042" title="deJonghT , Gurol‐UrganciI , Vodopivec‐JamsekV , CarJ , AtunR . Mobile phone messaging for facilitating self‐management of long‐term illnesses. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD007459.pub2] ">de Jongh 2012</a>; <a href="./references#CD012900-bbs2-0047" title="Gurol‐UrganciI , deJonghT , Vodopivec‐JamsekV , AtunR , CarJ . Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD007458.pub3] ">Gurol‐Urganci 2013</a>; <a href="./references#CD012900-bbs2-0058" title="LinH , WuX . Intervention strategies for improving patient adherence to follow‐up in the era of mobile information technology: a systematic review and meta‐analysis. PloS One2014;9:e104266. ">Lin 2014</a>; <a href="./references#CD012900-bbs2-0059" title="LiuQ , AbbaK , AlejandriaMM , SinclairD , BalanagVM , LansangMA . Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD006594.pub3] ">Liu 2014</a>; <a href="./references#CD012900-bbs2-0066" title="Pfaeffli DaleL , DobsonR , WhittakerR , MaddisonR . The effectiveness of mobile‐health behaviour change interventions for cardiovascular disease self‐management: a systematic review. European Journal of Preventive Cardiology2016;23(8):801‐17. ">Pfaeffli 2016</a>; <a href="./references#CD012900-bbs2-0077" title="SmithC , GoldJ , NgoTD , SumpterC , FreeC . Mobile phone‐based interventions for improving contraception use. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD011159.pub2] ">Smith 2015b</a>; <a href="./references#CD012900-bbs2-0081" title="ThakkarJ , KurupR , LabaTL , SantoK , ThiagalingamA , RodgersA , et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta‐analysis. JAMA Internal Medicine2016;176(3):340‐9. ">Thakkar 2016</a>; <a href="./references#CD012900-bbs2-0090" title="WhiteheadL , SeatonP . The effectiveness of self‐management mobile phone and tablet apps in long‐term condition management: a systematic review. Journal of Medical Internet Research2016;18(5):e97. ">Whitehead 2016</a>) including sickle cell disease (<a href="./references#CD012900-bbs2-0040" title="CrosbyLE , WareRE , GoldsteinA , WaltonA , JoffeNE , Vogel , C , et al. Development and evaluation of iManage: a self‐management app co‐designed by adolescents with sickle cell disease. Pediatric Blood &amp; Cancer2017;64(1):139‐45. ">Crosby 2017</a>; <a href="./references#CD012900-bbs2-0054" title="JonassaintCR , ShahN , JonassaintJ , DeCastroL . Usability and feasibility of an mHealth intervention for monitoring and managing pain symptoms in sickle cell disease: the sickle cell disease mobile application to record symptoms via technology (SMART). Hemoglobin2015;39(3):162‐8. ">Jonassaint 2015</a>) and thalassemia (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>; <a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>), though the cost‐effectiveness of such interventions warrants further investigation (<a href="./references#CD012900-bbs2-0028" title="BadawySM , KuhnsLM . Economic evaluation of text‐messaging and smartphone‐based Interventions to improve medication adherence in adolescents with chronic health conditions: a systematic review. JMIR Mhealth and Uhealth2016;4(4):e121. ">Badawy 2016c</a>). To date, the evidence for the use of computer and mobile technology interventions in people with thalassemia remains unclear. Although this systematic review may not yet identify any eligible studies, it is important to identify and report this knowledge gap in the field of thalassemia to highlight where future research efforts can be directed using computer and mobile technology interventions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012900-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012900-sec-0034"></div> <p>To identify and assess the effects of computer and mobile technology interventions designed to facilitate medication adherence and disease management in individuals with thalassemia, including: </p> <p> <ol id="CD012900-list-0003"> <li> <p>evaluating the effects of using computer and mobile technology interventions for medication adherence and disease management on health and behavioral outcomes; </p> </li> <li> <p>identifying and assessing the effects of computer and mobile technology interventions specific to different age groups (children, adolescents and adults) and type of modality (e.g. cell phone, the Internet). </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012900-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012900-sec-0035"></div> <section id="CD012900-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012900-sec-0037"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCT) and quasi‐RCTs comparing single‐ or multi‐component interventions versus no intervention, placebo or standard care. We also planned to include non‐randomized studies of interventions (NRSI): controlled before‐after (CBA) studies, and interrupted‐time‐series (ITS) studies. We used the Cochrane Effective Practice and Organization of Care (EPOC) Group’s definition of study designs to consider studies for inclusion (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>)*. </p> <p>Given the growing evidence in the field and the possible paucity of research studies, in particular RCTs, evaluating technology interventions in this population, we wanted to broaden our eligibility criteria to be able to report the up‐to‐date current status of the field and identify gaps. Therefore, we planned to include NRSI in this review. </p> <p>We planned to include cluster‐RCTs, non‐randomized cluster studies and CBA studies if they have at least two intervention sites and two control sites. However, we planned to exclude such studies with only one intervention or control site since the intervention (or comparison) could be confounded by the study site, thus making it difficult to attribute any observed differences to the intervention rather than to other site‐specific variables (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>). </p> <p>We also planned to include ITS and repeated‐measures studies which have a clearly defined point in time when the intervention occurred and at least three data points before and at least three data points after the intervention. We planned to exclude ITS studies that do not have a clearly defined point in time when the intervention occurred, fewer than three data points before and after the intervention, or if the ITS study has ignored secular (trend) changes, performed a simple t‐test of the pre‐ versus post‐intervention periods and re‐analysis of the data is not possible (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>). </p> <p>We planned to evaluate for the possible bias introduced by confounding in the different types of included studies, and we will adjust for confounder variables. Possible confounders include age and education of the participant, self‐management skills, personal behavior or personality traits, health literacy, parental involvement in medical care, parental education, household income, insurance status, access to healthcare services, type of thalassemia (TDT versus NTDT), associated co‐morbidities or complications (or both) affecting clinical course, and iron chelation regimen. </p> <p>We planned to exclude studies with a cross‐over design since any intervention focused on improving disease knowledge will leave that knowledge with a residual 'carry‐over' effect. </p> <p>* Please refer to '<a href="#CD012900-sec-0109">Differences between protocol and review</a>'. </p> </section> <section id="CD012900-sec-0038"> <h4 class="title">Types of participants</h4> <p>People with TDT or NTDT of all ages (children, adolescents and adults) or their parents or caregivers. </p> </section> <section id="CD012900-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Interventions delivered via cell phones (including smart phones), the Internet or other technology or mobile devices compared to other technology interventions or no interventions or standard of care or placebo. </p> <p>We planned to include remote and Web 2.0‐based interventions delivered via technologies that give people with thalassemia access to e‐health information to promote medication adherence and disease management. These e‐health technologies included personal computers (PCs) and applications (apps) for mobile technology such as iOS tablets (iPads), Android tablets and smartphones. </p> <p>We planned to include e‐health or technology‐based interventions that are focused on people with thalassemia and parents or caregivers to promote individual medication adherence and disease management and are self‐administered or user‐centred (where the intervention design process focuses on user needs). </p> <p>We also planned to include as possible comparison groups (whenever reported): face‐to‐face support; educational material (either as hard copy or digital documents); or self‐management tools (either as hard copy or digital documents). </p> <p>We planned to exclude studies that focus on monitoring devices, telemonitoring or telemedicine or other technologies that involve the participation of healthcare professionals. </p> </section> <section id="CD012900-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD012900-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD012900-list-0004"> <li> <p>Medication adherence</p> <ol id="CD012900-list-0005"> <li> <p>directly observed adherence rates with individuals recording their daily iron chelator use on their cell phones </p> </li> <li> <p>radiological markers of iron overload (MRI of liver R2* and MRI of heart T2*)</p> </li> <li> <p>laboratory markers of iron overload (serum ferritin levels)</p> </li> <li> <p>iron chelation adherence rates by pharmacy records (i.e. medication possession ratio)</p> </li> <li> <p>self‐reported iron chelator adherence rate</p> </li> </ol> </li> </ol> </p> </section> <section id="CD012900-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD012900-list-0006"> <li> <p>Knowledge about thalassemia</p> </li> <li> <p>Health outcomes (e.g. health‐related quality of life)</p> </li> <li> <p>User evaluation of the mobile technology interventions, including acceptability and satisfaction </p> </li> <li> <p>Adverse events (e.g. issues of privacy and disclosure, or failure or delay in the intervention delivery) </p> </li> </ol> </p> </section> </section> </section> <section id="CD012900-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all relevant published and unpublished trials without restrictions on language, year or publication status. </p> <section id="CD012900-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We searched the Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register using the terms: (thalassaemia OR (haemoglobinopathies AND general)) AND (mobile technology). </p> <p>The Haemoglobinopathies Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of the Cochrane Library) and weekly searches of MEDLINE. Unpublished work is identified by searching the abstract books of five major conferences: the European Haematology Association conference; the American Society of Hematology conference; the British Society for Haematology Annual Scientific Meeting; the Caribbean Public Health Agency Annual Scientific Meeting (formerly the Caribbean Health Research Council Meeting); and the National Sickle Cell Disease Program Annual Meeting. For full details of all searching activities for the register, please see the relevant section of the Cochrane Cystic Fibrosis and Genetic Disorders Group's <a href="http://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of the most recent search of the Haemoglobinopathies Trials Register: 20 June 2019. </p> <p>In addition to the above, we conducted a search of the following databases:·</p> <p> <ul id="CD012900-list-0007"> <li> <p>CENTRAL, Other Reviews (DARE) and Technology Assessments (HTA) Databases (the Cochrane Library) (22 February 2018) (<a href="http://www.cochranelibrary.com/" target="_blank">www.cochranelibrary.com/</a>); </p> </li> <li> <p>PubMed (Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, for recent records not yet added to MEDLINE) (22 February 2018) (<a href="http://www.ncbi.nlm.nih.gov/sites/entrez" target="_blank">www.ncbi.nlm.nih.gov/sites/entrez</a>); </p> </li> <li> <p>MEDLINE (OvidSP, Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE, 1946 to 22 February 2018); </p> </li> <li> <p>Embase (OvidSP, 1974 to 22 February 2018);</p> </li> <li> <p>CINAHL (EBSCOHost, 1937 to 22 February 2018);</p> </li> <li> <p>PsycInfo (EBSCOHost, 1900 to 22 February 2018);</p> </li> <li> <p>ProQuest Dissertations &amp; Theses Global (ProQuest, 1861 to 22 February 2018);</p> </li> <li> <p>Web of Science &amp; Social Sciences Conference Proceedings Indexes (CPSI‐S &amp; CPSSI, 1990 to 22 February 2018); </p> </li> <li> <p>Institute of Electrical and Electronics Engineers Explore (IEEE Xplore, 1963 to 22 February 2018). </p> </li> </ul> </p> <p>Additionally, we searched the following trial databases for trials (22 February 2018):</p> <p> <ul id="CD012900-list-0008"> <li> <p>ISRCTN registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.ClinicalTrials.gov</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> </li> </ul> </p> <p>See <a href="./appendices#CD012900-sec-0103">Appendix 1</a> for the full search strategies. </p> </section> <section id="CD012900-sec-0045"> <h4 class="title">Searching other resources</h4> <p>We aimed to further identify unpublished work by searching the abstract books of the International Society for Research on Internet interventions (ISRII); the NIH Wireless Health Conference; the Society for Behavioral Medicine (SBM) Annual Meeting; and the Connected Health Conference over the past 10 years (2007 to 2018). </p> <section id="CD012900-sec-0046"> <h5 class="title">Reference lists</h5> <p>The reference lists of all included articles and relevant systematic reviews were reviewed to identify any additional studies. We planned to contact the lead authors of the included studies to identify any unpublished material, missing data or information regarding ongoing relevant studies. </p> </section> </section> </section> <section id="CD012900-sec-0047"> <h3 class="title" id="CD012900-sec-0047">Data collection and analysis</h3> <section id="CD012900-sec-0048"> <h4 class="title">Selection of studies</h4> <p>We selected studies according to chapter 7 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0050" title="HigginsJPT , DeeksJJ , editor(s) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). Two review authors (SB and KM) independently screened all electronically derived citations and abstracts of papers identified by the search strategy for relevance. We excluded all articles that are clearly irrelevant at this stage based on the title and the abstract. Two review authors (SB and KM) independently assessed the full texts of all potentially relevant studies for eligibility against criteria outlined above. If a consensus could not be reached, we resolved any disagreements by discussion and consultation with a third review author (TP). We planned to seek further information from study authors if studies or abstracts contain insufficient data to make a decision about eligibility. We designed a study eligibility form which included ascertaining whether the participants have thalassaemia, if the study addressed mobile technology interventions to improve disease management, and whether the study was randomized or a NRSI or a CBA or an ITS study. We also recorded the reasons why potentially relevant studies failed to meet the eligibility criteria. </p> </section> <section id="CD012900-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SB and KM) planned to conduct data extraction according to Cochrane guidelines (<a href="./references#CD012900-bbs2-0049" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>) and according to the criteria developed for NRSI as recommended in chapter 13 of the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0070" title="ReevesBC , DeeksJJ , HigginsJPT , Wells GA on behalf of the Cochrane Non‐Randomised Studies Methods Group. Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Reeves 2011</a>). We aimed to resolve any disagreements by consensus. We planned to pilot data extraction forms for RCTs, NRSI or CBAs or ITS studies; thereafter, data extraction is planned to be conducted by two authors (SB and KM) independently for all the studies using templates modified to reflect the outcomes in this review. In addition, we planned to use the available tables in Review Manager 5 (<a href="./references#CD012900-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to extract data on study characteristics as below. </p> <section id="CD012900-sec-0050"> <h5 class="title">General information</h5> <p>Review author’s name, date of data extraction, study ID, first author of study, author’s contact address (if available), citation of paper, and objectives of the study. </p> </section> <section id="CD012900-sec-0051"> <h5 class="title">Study details</h5> <p>Study design, location, setting, sample size, power calculation, treatment allocation, inclusion and exclusion criteria, reasons for exclusion, comparability of groups, length of follow‐up, stratification, stopping rules described, statistical analysis, results, conclusion, and funding. </p> </section> <section id="CD012900-sec-0052"> <h5 class="title">Characteristics of participants</h5> <p>Age, gender, total number recruited, total number randomized, total number analyzed, types of underlying disease, loss to follow‐up numbers, dropouts (percentage in each arm) with reasons, protocol violations (if any), and co‐morbidities. </p> </section> <section id="CD012900-sec-0053"> <h5 class="title">Interventions</h5> <p>Details of the mobile technology interventions including purpose (e.g. adherence promotion), modality used (cell phone, the Internet or other technology), length of intervention, how the intervention is being delivered (i.e. electronically only or electronically in addition to group, face‐to‐face, written information) and by whom (i.e. clinicians, researchers, patients or parents) and where the intervention is being delivered (i.e. hospital, clinic, home or other settings). We planned to analyse data from different modes of interventions separately (e.g. cell phone versus standard care, Internet versus standard care, etc.). </p> </section> <section id="CD012900-sec-0054"> <h5 class="title">Outcomes measured</h5> <p>Data on measures of medication adherence, including iron chelation adherence rates by self‐report or pharmacy records (or both) (i.e. medication possession ratio), laboratory markers of iron overload (serum ferritin level), radiological markers of iron overload (MRI of liver R2* and MRI of heart T2*), and other reported adherence indicators; also data on knowledge about thalassemia and health outcomes (e.g. health‐related quality of life). </p> <p>Data on user perception of acceptability and satisfaction (e.g. the Likert ratings of satisfaction). Adverse events if reported and whether or not they were associated with interventions. </p> <p>For NRSI, CBA or ITS studies, data on: confounding factors; the comparability of groups on confounding factors; methods used to control for confounding and on multiple effect estimates (both unadjusted and adjusted estimates) as recommended in chapter 13 of the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0070" title="ReevesBC , DeeksJJ , HigginsJPT , Wells GA on behalf of the Cochrane Non‐Randomised Studies Methods Group. Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Reeves 2011</a>). We used both full‐text versions and abstracts as data sources and we used one data extraction form for each unique study. Where sources did not provide sufficient information, we planned to contact authors and study groups for additional details. We planned for one review author to enter data and for a second to check these data for accuracy. </p> </section> </section> <section id="CD012900-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>In future, two review authors (SB and KM) will assess included studies for possible risks of bias as described in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0051" title="HigginsJPT , AltmanDG , SterneJAC , editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). In our assessment, we will include information about the design, the conduct and the analysis of the study. </p> <section id="CD012900-sec-0056"> <h5 class="title">RCTs</h5> <p>We planned to assess each criterion using Cochrane's RoB (V2.0) tool for assessing the risk of bias for RCTs (classed as 'low risk', 'high risk' or 'some concerns' for bias) in the following areas (<a href="./references#CD012900-bbs2-0051" title="HigginsJPT , AltmanDG , SterneJAC , editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). </p> <section id="CD012900-sec-0057"> <h6 class="title">Bias arising from the randomization process</h6> <p> <ol id="CD012900-list-0009"> <li> <p>Was the allocation sequence random?</p> </li> <li> <p>Was the allocation sequence concealed until participants were recruited and assigned to interventions? </p> </li> <li> <p>Were there baseline imbalances that suggest a problem with the randomization process?</p> </li> <li> <p>What is the predicted direction of bias arising from the randomization process?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0058"> <h6 class="title">Bias due to deviations from intended interventions</h6> <p> <ol id="CD012900-list-0010"> <li> <p>Were participants aware of their assigned intervention during the RCT?</p> </li> <li> <p>Were carers and trial personnel aware of participants' assigned intervention during the RCT? </p> </li> <li> <p>Were there deviations from the intended intervention beyond what would be expected in usual practice? </p> </li> <li> <p>Were these deviations from intended intervention unbalanced between groups and likely to have affected the outcome? </p> </li> <li> <p>Were any participants analysed in a group different from the one to which they were assigned? </p> </li> <li> <p>Was there potential for a substantial impact (on the estimated effect of intervention) of analysing participants in the wrong group? </p> </li> <li> <p>What is the predicted direction of bias due to deviations from intended interventions?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0059"> <h6 class="title">Bias due to missing outcome data</h6> <p> <ol id="CD012900-list-0011"> <li> <p>Were outcome data available for all, or nearly all, participants randomized?</p> </li> <li> <p>Are the proportions of missing outcome data and reasons for missing outcome data similar across intervention groups? </p> </li> <li> <p>Is there evidence that results were robust to the presence of missing outcome data?</p> </li> <li> <p>What is the predicted direction of bias due to missing outcome data?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0060"> <h6 class="title">Bias in measurement of the outcome</h6> <p> <ol id="CD012900-list-0012"> <li> <p>Were outcome assessors aware of the intervention received by participants?</p> </li> <li> <p>Was the assessment of the outcome likely to be influenced by knowledge of intervention received? </p> </li> <li> <p>What is the predicted direction of bias due to measurement of the outcome?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0061"> <h6 class="title">Bias in selection of the reported result(s)</h6> <p> <ol id="CD012900-list-0013"> <li> <p>Are the reported outcome data likely to have been selected, on the basis of the results, from multiple outcome measurements (e.g. scales, definitions, time points) within the outcome domain? Or from multiple analyses of the data? </p> </li> <li> <p>What is the predicted direction of bias due to selection of the reported result?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0062"> <h6 class="title">Overall bias</h6> <p>An overview of the overall bias identified.</p> </section> </section> <section id="CD012900-sec-0063"> <h5 class="title">NRSI studies</h5> <p>We planned to use the ROBINS‐I tool (Risk Of Bias In Non‐randomized Studies of Interventions) to rate the quality of NRSI or CBA studies (<a href="./references#CD012900-bbs2-0079" title="SterneJA , HernánMA , ReevesBC , SavovićJ , BerkmanND , ViswanathanM , et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ2016;355:i4919. ">Sterne 2016</a>). The ROBINS‐I tool uses signalling questions and covers seven domains (listed below) where the quality of evidence is rated as 'low', 'moderate', 'serious', 'critical' or 'no information'. </p> <section id="CD012900-sec-0064"> <h6 class="title">Bias due to confounding</h6> <p> <ol id="CD012900-list-0014"> <li> <p>Is there potential for confounding of the effect of intervention in this study?</p> </li> <li> <p>Was the analysis based on splitting participants’ follow‐up time according to intervention received? </p> </li> <li> <p>Were intervention discontinuations or switches likely to be related to factors that are prognostic for the outcome? </p> </li> <li> <p>Did the authors use an appropriate analysis method that controlled for all the important confounding domains? </p> </li> <li> <p>Were confounding domains that were controlled for measured validly and reliably by the variables available in this study? </p> </li> <li> <p>Did the authors control for any post‐intervention variables that could have been affected by the intervention? </p> </li> <li> <p>Did the authors use an appropriate analysis method that adjusted for all the important confounding domains and for time varying confounding? </p> </li> <li> <p>Were confounding domains that were adjusted for measured validly and reliably by the variables available in this study? </p> </li> </ol> </p> </section> <section id="CD012900-sec-0065"> <h6 class="title">Bias in the selection of participants into the study</h6> <p> <ol id="CD012900-list-0015"> <li> <p>Was selection of participants into the study (or into the analysis) based on participant characteristics observed after the start of intervention? </p> </li> <li> <p>Were the post‐intervention variables that influenced selection likely?</p> </li> <li> <p>Were the post‐intervention variables that influenced selection likely to be influenced by the outcome or a cause of the outcome? </p> </li> <li> <p>Do start of follow‐up and start of intervention coincide for most participants?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0066"> <h6 class="title">Bias in classification of interventions</h6> <p> <ol id="CD012900-list-0016"> <li> <p>Were intervention groups clearly defined?</p> </li> <li> <p>Was the information used to define intervention groups recorded at the start of the intervention? </p> </li> <li> <p>Could classification of intervention status have been affected by knowledge of the outcome or risk of the outcome? </p> </li> <li> <p>What is the predicted direction of bias due to measurement of outcomes or interventions?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0067"> <h6 class="title">Bias due to deviation from intended interventions</h6> <p> <ol id="CD012900-list-0017"> <li> <p>Were there deviations from the intended intervention beyond what would be expected in usual practice? </p> </li> <li> <p>Were these deviations from intended intervention unbalanced between groups and likely to have affected the outcome? </p> </li> <li> <p>Were important co‐interventions balanced across intervention groups?</p> </li> <li> <p>Was the intervention implemented successfully for most participants?</p> </li> <li> <p>Did study participants adhere to the assigned intervention regimen?</p> </li> <li> <p>Was an appropriate analysis used to estimate the effect of starting and adhering to the intervention? </p> </li> <li> <p>What is the predicted direction of bias due to deviations from the intended interventions?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0068"> <h6 class="title">Bias due to missing data</h6> <p> <ol id="CD012900-list-0018"> <li> <p>Were outcome data available for all, or nearly all, participants?</p> </li> <li> <p>Were participants excluded due to missing data on intervention status?</p> </li> <li> <p>Were participants excluded due to missing data on other variables needed for the analysis?</p> </li> <li> <p>Are the proportion of participants and reasons for missing data similar across interventions?</p> </li> <li> <p>Is there evidence that results were robust to the presence of missing data?</p> </li> <li> <p>What is the predicted direction of bias due to missing data?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0069"> <h6 class="title">Bias in measurement of outcomes</h6> <p> <ol id="CD012900-list-0019"> <li> <p>Could the outcome measure have been influenced by knowledge of the intervention received?</p> </li> <li> <p>Were outcome assessors aware of the intervention received by study participants?</p> </li> <li> <p>Were the methods of outcome assessment comparable across intervention groups?</p> </li> <li> <p>Were any systematic errors in measurement of the outcome related to intervention received?</p> </li> <li> <p>What is the predicted direction of bias due to measurement of outcomes?</p> </li> </ol> </p> </section> <section id="CD012900-sec-0070"> <h6 class="title">Bias in the selection of the reported result</h6> <p> <ol id="CD012900-list-0020"> <li> <p>Is the reported effect estimate likely to be selected, on the basis of the results, from multiple outcome measurements within the outcome domain? Or from multiple analyses of the intervention outcome relationship? Or from different subgroups? </p> </li> <li> <p>What is the predicted direction of bias due to selection of the reported result?</p> </li> </ol> </p> </section> </section> <section id="CD012900-sec-0071"> <h5 class="title">ITS studies</h5> <p>For ITS studies, we planned to use the risk of bias criteria below as suggested for EPOC reviews (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>) as follows. </p> <p> <ol id="CD012900-list-0021"> <li> <p>Was the intervention independent of other changes?</p> </li> <li> <p>Was the shape of the intervention effect pre‐specified?</p> </li> <li> <p>Was the intervention unlikely to affect data collection?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> </li> <li> <p>Were incomplete outcome data adequately addressed?</p> </li> <li> <p>Was the study free from selective outcome reporting?</p> </li> <li> <p>Was the study free from other risks of bias?</p> </li> </ol> </p> <p>We planned to resolve disagreements on the assessment of quality of an included study by discussion until consensus is reached or by consultation with a third review author (TP). </p> </section> </section> <section id="CD012900-sec-0072"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012900-sec-0073"> <h5 class="title">RCTs</h5> <p>We planned to report the following continuous primary endpoints of medication adherence, including iron chelation adherence rates by self‐report or pharmacy records (i.e. medication possession ratio), laboratory markers of iron overload with serum ferritin level, radiological markers of iron overload (MRI of liver R2* and MRI of heart T2*), and other reported adherence indicators. We also planned to report the following continuous secondary endpoints (user evaluation of acceptability and satisfaction). </p> <p>For continuous endpoints, we planned to extract and report the absolute change from baseline using statistical analysis, adjusting for baseline differences, in both the treatment and control groups. We planned to record the mean, standard deviation (SD) and total number of participants in both the treatment and control groups. For those using the same scale or outcome, we planned to perform analyses using the mean difference (MD) with 95% confidence intervals (CIs). For those reported using different scales or outcomes, we planned to use the standardized mean difference (SMD). We planned to extract and report the relative change adjusted for baseline differences in the outcome measures (i.e. the absolute post‐intervention difference between the intervention and control groups, as well as the absolute pre‐intervention difference between the intervention and control groups divided by the post‐intervention level in the control group) (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>). </p> <p>For binary outcomes we planned to record the number of events and the total number of participants in both the treatment and control groups and report the pooled risk ratio (RR) with a 95% CI (<a href="./references#CD012900-bbs2-0043" title="DeeksJJ , HigginsJPT , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). Where the number of observed events was small (less than 5% of sample per group), and where studies have balanced treatment groups, we planned to report the Peto odds ratio (OR) with 95% CI (<a href="./references#CD012900-bbs2-0043" title="DeeksJJ , HigginsJPT , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> <p>For cluster‐RCTs, we planned to extract and report direct estimates of the effect measure (e.g. RR with a 95% CI) from an analysis that accounts for the clustered design. We planned to obtain statistical advice to ensure the analysis is appropriate. If appropriate analyses are not available, we planned to make every effort to approximate the analysis with necessary adjustment using effective sample size recalculation, following the recommendations in chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0052" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011d</a>). </p> <p>We planned to undertake quantitative assessments using the Review Manager (RevMan) software (<a href="./references#CD012900-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), if data allowed. </p> </section> <section id="CD012900-sec-0074"> <h5 class="title">NRSI studies</h5> <p>For continuous variables in any included studies, if available, we planned to extract and report the absolute change from baseline using statistical analysis, adjusting for baseline differences (such as regression models, mixed models or hierarchical models). An adjusted change of outcomes was required in NRSI and confounding was considered and evaluated in the included articles. If available, we planned to extract and report the relative change adjusted for baseline differences in the outcome measures (i.e. the absolute post‐intervention difference between the intervention and control groups, as well as the absolute pre‐intervention difference between the intervention and control groups divided by the post‐intervention level in the control group) (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>). </p> <p>For binary outcomes, if available we planned to extract and report the RR with a 95%CI from statistical analyses, adjusting for baseline differences (such as Poisson regressions or logistic regressions) or the ratio of RRs (i.e. the RR post intervention / risk ratio pre intervention). </p> </section> <section id="CD012900-sec-0075"> <h5 class="title">ITS studies</h5> <p>For ITS studies that fulfil the criteria of analysis, and from which relevant information can be extracted, we planned to standardize data by dividing the level (or time slope) and standard error (SE) by the SD of the pre‐intervention slope, in order to obtain the effect sizes. Where appropriate, we planned to report the number‐needed‐to‐treat‐to‐benefit (NNTB) and the number‐needed‐to‐treat‐to‐harm (NNTH) with 95% CIs. If we were not able to report the available data in any of the formats described above, we planned to produce a narrative report, and if appropriate, we planned to present the data in tables. </p> </section> </section> <section id="CD012900-sec-0076"> <h4 class="title">Unit of analysis issues</h4> <p>We planned to identify issues related to unit of analysis, given the inclusion of cluster‐RCTs or non‐randomized studies, and multiple observations for the same outcome. Therefore, if any of these study designs included in our review, we planned to treat these in accordance with the advice given in chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0052" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011d</a>). For cluster designs, we planned to extract results adjusted for clustering, and if analyses have not been adjusted for clustering, we planned to re‐analyze the data taking clustering and and individual participant data (IPD) into account, if possible; if not possible, we planned to present data in a table. If participants were randomized more than once, we planned to contact the authors of the study to provide us with data on outcomes associated with the initial randomization. For studies with multiple treatment groups we planned to include subgroups that were considered relevant to the analysis. When appropriate, we planned to combine groups to create a single pair‐wise comparison. If not possible, we planned to select the most appropriate pair of interventions and exclude the others (<a href="./references#CD012900-bbs2-0052" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011d</a>). We planned to deal with any unit of analysis issues arising from the inclusion of ITS studies according to the EPOC recommendations (<a href="./references#CD012900-bbs2-0045" title="Cochrane EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors, 2017. What study designs should be included in an EPOC review and what should they be called?. www.epoc.cochrane.org/epoc‐resources‐review‐authors (accessed 15 June 2017). ">EPOC 2017</a>). We planned to analyze ITS studies as a statistical comparison of time trends before and after the intervention. In time‐series analysis, there are a number of statistical techniques that could be used depending on the characteristics of the data, the number of data points available and whether autocorrelation was present (e.g. auto‐regressive integrated moving average 'ARIMA' model). </p> </section> <section id="CD012900-sec-0077"> <h4 class="title">Dealing with missing data</h4> <p>If we identified incidences where we suspected data were missing or unclear, we planned to contact study authors directly. We planned to record the number of participants lost to follow‐up for each study. Where possible, we planned to analyze data on an intention‐to‐treat (ITT) basis, but if insufficient data had been available, we planned to present per protocol analyses (<a href="./references#CD012900-bbs2-0051" title="HigginsJPT , AltmanDG , SterneJAC , editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). </p> </section> <section id="CD012900-sec-0078"> <h4 class="title">Assessment of heterogeneity</h4> <p>If the clinical and methodological characteristics of individual studies are sufficiently homogeneous, we planned to combine the data to perform a meta‐analysis. We planned to analyze the data from RCTs, NRSI, CBA and ITS studies separately. We planned to assess the statistical heterogeneity of treatment effects between studies using a Chi² test with a significance level at P &lt; 0.1. We planned to use the I² statistic to quantify the degree of potential heterogeneity and classify it as moderate if I² is greater than 50%, or considerable if I² is greater than 75%. If statistical heterogeneity is moderate within the studies selected for inclusion; in such cases, we planned to use the random‐effects model. If statistical heterogeneity is considerable within the studies selected for inclusion, we planned not to report the overall summary statistic. When possible, we planned to assess the potential causes of heterogeneity by sensitivity and subgroup analyses (<a href="./references#CD012900-bbs2-0043" title="DeeksJJ , HigginsJPT , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD012900-sec-0079"> <h4 class="title">Assessment of reporting biases</h4> <p>Where we identified at least 10 studies for inclusion in a meta‐analysis, we planned to explore potential publication bias with a funnel plot and using a linear regression test. We planned to consider a P value of less than 0.1 as significant for this test (<a href="./references#CD012900-bbs2-0078" title="SterneJAC , EggerM , MoherD , editor(s) on behalf of the Cochrane Bias Methods Group. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> </section> <section id="CD012900-sec-0080"> <h4 class="title">Data synthesis</h4> <p>If studies were sufficiently homogenous in their study design, we planned to conduct a meta‐analysis according to Cochrane recommendations (<a href="./references#CD012900-bbs2-0043" title="DeeksJJ , HigginsJPT , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). We planned to analyze RCTs and non‐RCTs separately using the random‐effects model as the true effects are expected to be related but not the same for included studies. If we cannot perform a meta‐analysis, we planned to include a narrative describing the results and the results from all studies presented in the tables. </p> <p>For RCTs, where meta‐analysis was feasible, we planned to use the inverse variance method for continuous outcomes, or outcomes that included data from cluster‐RCTs. If we found heterogeneity to be above 75%, and we identified a possible cause for the heterogeneity, we planned to investigate these with subgroup analyses. If a cause for the heterogeneity cannot be found, then we planned not to perform a meta‐analysis. </p> <p>If meta‐analysis was feasible for NRSI or CBA studies, we planned to analyze these separately. We planned only to analyze outcomes with adjusted effect estimates, if these are adjusted for the same factors using the inverse variance method as recommended in chapter 13 of the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0070" title="ReevesBC , DeeksJJ , HigginsJPT , Wells GA on behalf of the Cochrane Non‐Randomised Studies Methods Group. Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Reeves 2011</a>). </p> <p>If meta‐analysis was feasible for ITS studies, we planned to use the effect sizes (if reported in the included studies or obtained, as described earlier) and we planned to pool these using the generic inverse variance method in RevMan (<a href="./references#CD012900-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> <p>We planned to report data for our listed outcomes at the following time points: pre‐intervention; immediate post‐intervention; and at first follow‐up (up to 12 months). </p> </section> <section id="CD012900-sec-0081"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If adequate data were available, we planned to perform subgroup analyses according to Cochrane recommendations (<a href="./references#CD012900-bbs2-0043" title="DeeksJJ , HigginsJPT , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>) for each of the following criteria, and separately for the different study design types included in the review in order to assess the effect on heterogeneity. We planned to base the subgroup analyses on: </p> <p> <ol id="CD012900-list-0022"> <li> <p>delivery mode, phone‐based versus Internet‐based interventions;</p> </li> <li> <p>age groups, children (8 to 11 years old) (parent‐focused) versus adolescents (12 to 17 years old) versus adults (18 years and above); </p> </li> <li> <p>transfusion‐dependent versus non‐transfusion‐dependent thalassemia; and</p> </li> <li> <p>iron‐chelation regimen, deferasirox versus deferoxamine versus deferiprone.</p> </li> </ol> </p> </section> <section id="CD012900-sec-0082"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to assess the robustness of the review findings by performing the following sensitivity analyses according to Cochrane recommendations where appropriate (<a href="./references#CD012900-bbs2-0043" title="DeeksJJ , HigginsJPT , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>): </p> <p> <ol id="CD012900-list-0023"> <li> <p>including only those studies with a 'low' risk of bias (e.g. RCTs with methods assessed as low risk for random sequence generation and concealment of treatment allocation); </p> </li> <li> <p>including only those studies with less than a 20% dropout rate.</p> </li> </ol> </p> <section id="CD012900-sec-0083"> <h5 class="title">Summary of findings table</h5> <p>We plan to use the GRADE approach to generate a 'Summary of Findings' table as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012900-bbs2-0074" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Presenting results and ‘Summary of findings’ tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011a</a>). We will rate the quality of the evidence as 'high', 'moderate', 'low', or 'very low' using the five GRADE considerations. </p> <p> <ol id="CD012900-list-0024"> <li> <p>Risk of bias (serious or very serious)</p> </li> <li> <p>Inconsistency (serious or very serious)</p> </li> <li> <p>Indirectness (serious or very serious)</p> </li> <li> <p>Imprecision (serious or very serious)</p> </li> <li> <p>Publication bias (likely or very likely)</p> </li> </ol> </p> <p>For non‐RCTs or CBA or ITS studies, we will also consider the following factors:</p> <p> <ol id="CD012900-list-0025"> <li> <p>dose response (yes or no);</p> </li> <li> <p>size of effect (large or very large);</p> </li> <li> <p>confounding either reduces the demonstrated effect or increases the effect if no effect was observed (yes or no). </p> </li> </ol> </p> <p>When using GRADE, we planned to initially rate NRSI or CBA or ITS studies as low quality and upgrade according to GRADE guidelines if appropriate. We planned to present the outcomes for these studies in separate tables from outcomes for the results of RCTs. We planned to report the following outcomes in each 'Summary of findings' table: </p> <p> <ol id="CD012900-list-0026"> <li> <p>directly observed adherence rates with individuals recording their daily iron chelator use on their cell phones; </p> </li> <li> <p>radiological markers of iron overload (MRI of liver R2* and MRI of heart T2*);</p> </li> <li> <p>laboratory markers of iron overload (serum ferritin levels);</p> </li> <li> <p>iron chelation adherence rates by pharmacy records (i.e. medication possession ratio);</p> </li> <li> <p>self‐reported iron chelation adherence rate;</p> </li> <li> <p>disease knowledge about thalassemia; and</p> </li> <li> <p>health outcomes (e.g. health‐related quality of life).</p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012900-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012900-sec-0084"></div> <section id="CD012900-sec-0085"> <h3 class="title">Description of studies</h3> <p>See Characteristics of included studies; <a href="./references#CD012900-sec-0111" title="">Characteristics of excluded studies</a>. </p> <section id="CD012900-sec-0086"> <h4 class="title">Results of the search</h4> <p>See PRISMA flow diagram (<a href="#CD012900-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD012900-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012900-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012900.pub2/media/CDSR/CD012900/image_n/nCD012900-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>In the searches for this review we identified a total of 3838 potentially relevant references. There were 3370 references after we removed duplicates and two review authors (SB and KM) excluded 3345 references on the basis of the title and the abstract. Two authors (SB and KM) reviewed 25 references for relevance. We did not identify any completed NRSI or any RCTs, cluster‐RCTs, CBA or ITS studies that met the inclusion criteria. We have listed two RCTs as ongoing studies and we excluded 20 studies (23 references) that did not meet our pre‐defined inclusion criteria. We resolved disagreements by discussion and consultation with a third senior review author (TP). </p> </section> <section id="CD012900-sec-0087"> <h4 class="title">Included studies</h4> <p>No studies were identified for inclusion in the review.</p> </section> <section id="CD012900-sec-0088"> <h4 class="title">Excluded studies</h4> <p>We excluded 20 studies after full‐text screening for the following reasons. Six studies did not use technology interventions (<a href="./references#CD012900-bbs2-0001" title="Abu SamraO , AudaW , KamhawyH , Al‐TonbaryY . Impact of educational programme regarding chelation therapy on the quality of life for B‐thalassemia major children. Hematology2015;20(5):297‐303. ">Abu Samra 2015</a>; <a href="./references#CD012900-bbs2-0007" title="DehkordiAH , HeydarnejadMS . Effect of booklet and combined method on parents' awareness of children with beta‐thalassemia major disorder. Journal of the Pakistan Medical Association2008;58(9):485‐7. ">Dehkordi 2008</a>; <a href="./references#CD012900-bbs2-0008" title="GambariR , DiPaolaML , KleanthousM . Thalassemia on the WEB: From laboratory research to e‐dissemination. Minerva Biotecnologica2007;19:117‐22. ">Gambari 2007</a>; <a href="./references#CD012900-bbs2-0013" title="OlivieriNF , MatsuiD , HermannC , KorenG . Compliance assessed by the Medication Event Monitoring System. Archives of Disease in Childhood1991;66(12):1399‐402. ">Olivieri 1991</a>; <a href="./references#CD012900-bbs2-0014" title='PaholpakS , JetsrisuparbA , WiangnonS , SangsahachatD , PadtawaroLO . Result of video‐education on "genetic transmission in thalassemia" to thalassemic patients and their parents. Journal of the Medical Association of Thailand2006;89(11):1909‐14. '>Paholpak 2006</a>; <a href="./references#CD012900-bbs2-0018" title="TrachtenbergFL , MartinM , GreenS , OliverosO , CarsonS , GerstenbergerE , et al. Use of electronic data collection to assess pain in thalassaemia: a feasibility study. International Journal of Palliative Nursing2012;18(9):441‐5. ">Trachtenberg 2012b</a>). Six studies used physician‐centered technology interventions, defined as interventions developed for physicians or other healthcare providers to enhance their communications with patients and families or documentation of their medical evaluation and management, such as electronic health records (<a href="./references#CD012900-bbs2-0002" title="AntoniouZ , SchizaEC , NeokleousK , AngastiniotisM , PattichisCS , SchizasCN . eHealth Services for the European Reference Network on Rare Anaemias (eENERCA). Studies in Health Technology and Informatics2015;213:153‐6. ">Antoniou 2015</a>; <a href="./references#CD012900-bbs2-0003" title="ArbaiyN , SulaimanSE , HassanN , AfipZA . Integrated Knowledge Based Expert System for Disease Diagnosis System. IOP Conference Series: Materials Science and Engineering2017;226. ">Arbaiy 2017</a>; <a href="./references#CD012900-bbs2-0006" title="DeftereosS , LambrinoudakisC , AndriopoulosP , FarmakisD , AessoposA . A Java‐based electronic healthcare record software for beta‐thalassaemia. Journal of Medical Internet Research2001;3:E33. ">Deftereos 2001</a>; <a href="./references#CD012900-bbs2-0010" title="LedererCW , BasakAN , AydinokY , ChristouS , El‐BeshlawyA , Eleftheriou , A , et al. An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro‐mediterranean ITHANET project. Hemoglobin2009;33(3):163‐76. ">Lederer 2009</a>; <a href="./references#CD012900-bbs2-0016" title="PigaA , LongoF , MusallamKM , CappelliniMD , ForniGL , QuartaG , et al. Assessment and management of iron overload in beta‐thalassaemia major patients during the 21st century: a real‐life experience from the Italian WEBTHAL project. British Journal of Haematology2013;161(6):872‐83. ">Piga 2013</a>; <a href="./references#CD012900-bbs2-0017" title="SantiniS , PescapéA , ValenteAS , AbateV , ImprotaG , TriassiM , et al. Using fuzzy logic for improving clinical daily‐care of β‐thalassemia patients. IEEE International Conference on Fuzzy Systems (FUZZ‐IEEE), Naples, Italy. 2017:1‐6. ">Santini 2017</a>). Six studies were not original clinical research studies (<a href="./references#CD012900-bbs2-0004" title="BalP , ShamsirS , WandN , YahyaA , YunusJ , SupriyantoE , et al. MHealth Application: Mobile Thalassemia Patient Management Application. IEEE Conference on Biomedical Engineering and Sciences (IECBES), Kuala Lumpur, Malaysia. 2014:792‐6. ">Bal 2014</a>; <a href="./references#CD012900-bbs2-0005" title="BobatiSS , ViragiSV . Implementation of upgraded technology in the management of thalassemic patients‐an excellent response covering 14 districts Of North Karnataka. Indian Journal of Hematology and Blood Transfusion2016;32:S483‐S484. ">Bobati 2016</a>; <a href="./references#CD012900-bbs2-0009" title="JonassaintJ , DeCastroLM . Information technology use by patients with hemoglobinopathies. Blood2012;120(21). [Abstract No.: 4698] ">Jonassaint 2012</a>; <a href="./references#CD012900-bbs2-0012" title="NawazF , GilmoreA , Naorose‐AbidiS , ChoG . Haemoglobinopathy patient access to modern communication technology: The feasibility of alternative communication strategies to manage clinic appointments. Haematologica2012;97(Suppl 1):388. [Abstract No.: 0938] ">Nawaz 2012</a>; <a href="./references#CD012900-bbs2-0015" title="PaokantaP , HarnpornchaiN , CecarelliM , VivasC , SequeiraP . A Knowledge Creation Innovation for Web‐Knowledge‐Base System Using Knowledge Management, and Data and Knowledge Engineering. Proceedings of the European Conference on Knowledge Management (ECKM), Santarem, Portugal. 2014; Vol. 3:1255‐64. ">Paokanta 2014</a>; <a href="./references#CD012900-bbs2-0020" title="YamashitaRC , QuiroloK , ChoyJ , FooteD . From a distance:using information technologies to overcome geographic boundaries in thalassemia service delivery. Annals of the New York Academy of Sciences1998;850:518‐20. ">Yamashita 1998</a>). Two studies were an inappropriate design, uncontrolled before after pilot study (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>) and intervention development and usability pilot study (<a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). </p> <section id="CD012900-sec-0089"> <h5 class="title">Ongoing studies</h5> <p>We identified two ongoing RCTs that we plan to assess in a future update (<a href="./references#CD012900-bbs2-0021" title="IRCT20170826035907N1 . The effect of self‐caring using Tele‐Nursing on thalassemia teenagers self‐efficacy [Determining effect of self‐caring using Tele‐Nursing on major thalassemia teenagers self‐efficacy]. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20170826035907N1 (first received 01 January 2018). ">IRCT20170826035907N1</a>; <a href="./references#CD012900-bbs2-0022" title="IRCT20180207038655N1 . The effect of mobile phone‐based education on patients with thalassemia [The Effect of Mobile Phone‐Based Education for Improving Stress, Anxiety, Depression and Pain of Patients with Beta Thalassemia Major]. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20180207038655N1 (first received 11 March 2018). ">IRCT20180207038655N1</a>). </p> </section> </section> </section> <section id="CD012900-sec-0090"> <h3 class="title">Risk of bias in included studies</h3> <p>No studies were identified for inclusion in the review.</p> </section> <section id="CD012900-sec-0091"> <h3 class="title" id="CD012900-sec-0091">Effects of interventions</h3> <p>No studies were identified for inclusion in the review.</p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012900-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012900-sec-0092"></div> <p>For people with thalassemia, long‐term RBC transfusion remains the mainstay of therapy. This may lead to iron overload causing severe complications and damage in different body organs, with the heart, liver and endocrine glands being particularly vulnerable. Using data from six state Medicaid programs (1997 to 2013), a recent research study has shown that adherence to iron chelation ranges from 20% to 66% in people with thalassemia, which varies based on the type of iron chelator (<a href="./references#CD012900-bbs2-0086" title="VekemanF , SasaneM , ChengWY , RamanakumarAV , FortierJ , QiuY , et al. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. Journal of Medical Economics2016;19(3):292‐303. ">Vekeman 2016</a>). Similar data were recently reported in two systematic reviews for iron chelation adherence rates in people with sickle cell disease, 22% to 89% (<a href="./references#CD012900-bbs2-0060" title="LoiselleK , LeeJL , SzulczewskiL , DrakeS , CrosbyLE , PaiAL . Systematic and meta‐analytic review: medication adherence among pediatric patients with sickle cell disease. Journal of Pediatric Psychology2016;41(4):406‐18. ">Loiselle 2016</a>) and 16% to 89% (<a href="./references#CD012900-bbs2-0087" title="WalshKE , CutronaSL , KavanaghPL , CrosbyLE , MaloneC , LobnerK , et al. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics2014;134(6):1175‐83. ">Walsh 2014</a>). </p> <p>We identified two published studies that used mobile‐based interventions to improve adherence to iron chelation in people with thalassemia (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>; <a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). The Ward study included 35 people with thalassemia (aged 18 to 34 years), who were part of a Delphi process to inform the development of a mobile app to improve disease self‐management, including adherence to chelation therapy (<a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). The research team was able to develop and test the mobile app with participants who perceived it as highly favorable with improved adherence to iron chelation and positive experience using it, especially the adherence pledge functionality and customized treatment goals (<a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). The Leonard study included 11 people (β‐thalassemia major and sickle cell anemia) receiving chronic blood transfusions and evaluated a mobile app intervention as part of an intensive training program to improve disease self‐management, including adherence to iron chelation (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>). The authors reported on the feasibility of the mobile app intervention and that there was high acceptability and improved disease knowledge, as well as adherence to iron chelation (using medication possession ratio with pharmacy records and laboratory markers of adherence) with serum ferritin levels trending downwards (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>). However, these two studies were not included in this review because of inappropriate design, uncontrolled before after pilot study (<a href="./references#CD012900-bbs2-0011" title='LeonardS , AndersonLM , JonassaintJ , JonassaintC , ShahN . Utilizing a novel mobile health "Selfie" application to improve compliance to iron chelation in pediatric patients receiving chronic transfusions. Journal of Pediatric Hematology/Oncology2017;39(3):223‐9. LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology for intensive training in medication management in the pediatric population. Blood2014;124(21). [Abstract No.: 4842] LeonardS , JonassaintJ , AndersonL , ShahN . The use of mobile technology to provide intensive training for oral chelation management in pediatric sickle cell disease and beta‐thalassemia. Pediatric Blood and Cancer2015;62:S47‐S48. LeonardS , JonassaintJ , AndersonL , ShahN . Use of Mobile Technology for Intensive Training in Medication Management. https://clinicaltrials.gov/ct2/show/NCT02133560 (accessed 28 May 2019). '>Leonard 2017</a>) and intervention development and usability pilot study (<a href="./references#CD012900-bbs2-0019" title="WardR , TahaKM . Patient involvement as experts in the development and assessment of a smartphone app as a patient education tool for the management of thalassemia and iron overload syndromes. Hemoglobin2016;40(5):323‐9. ">Ward 2016</a>). </p> <section id="CD012900-sec-0093"> <h3 class="title" id="CD012900-sec-0093">Summary of main results</h3> <p>We found no evidence in the form of RCTs, cluster‐RCTs, CBA or ITS studies that met the inclusion criteria. We identified two ongoing RCTs that will be assessed further in a future update of this review. </p> </section> <section id="CD012900-sec-0094"> <h3 class="title" id="CD012900-sec-0094">Overall completeness and applicability of evidence</h3> <p>This review provides the most up‐to‐date assessment of the evidence for computer and mobile technology interventions designed to promote adherence to iron chelation therapy and disease management in people with thalassemia. The results of this review should be interpreted with caution and only in consideration of the following factors. </p> <p> <ol id="CD012900-list-0027"> <li> <p>We did not identify any RCTs, cluster‐RCTs, CBA or ITS studies that met the inclusion criteria; we identified two ongoing RCTs that may be eligible in a future update of this review. </p> </li> <li> <p>Due to lack of evidence, this review cannot comment on the efficacy or effectiveness of computer and mobile technology intervention strategies to promote disease management and adherence to iron chelation therapy in people with thalassemia. </p> </li> </ol> </p> </section> <section id="CD012900-sec-0095"> <h3 class="title" id="CD012900-sec-0095">Quality of the evidence</h3> <p>No studies were identified for inclusion in the review.</p> </section> <section id="CD012900-sec-0096"> <h3 class="title" id="CD012900-sec-0096">Potential biases in the review process</h3> <p>To our knowledge, our review process was free from bias. We conducted a comprehensive search: searching data sources (including multiple databases, and clinical trial registries) to ensure that all relevant studies would be captured. We had no restrictions for the language in which the paper was originally published. We carefully evaluated the relevance of each potentially‐eligible paper. </p> </section> <section id="CD012900-sec-0097"> <h3 class="title" id="CD012900-sec-0097">Agreements and disagreements with other studies or reviews</h3> <p>There have been limited data from published intervention studies to address adherence to iron chelation or disease management in people with thalassemia. </p> <p>A study by Bahnasawy evaluated the effect of an intervention with clinical pharmacist services, including detection of drug‐related problems and their management, education about β‐thalassemia and iron chelators, and individually‐tailored medication charts, compared to standard of care in 48 people with β‐thalassemia (<a href="./references#CD012900-bbs2-0033" title="BahnasawySM , ElWakeelLM , BeblawyNE , El‐HamamsyM . Clinical pharmacist‐provided services In iron‐overloaded beta‐thalassaemia major children: a new insight Into patient care. Basic Clinical &amp; Pharmacology &amp; Toxicology2017;120(4):354‐9. ">Bahnasawy 2017</a>). At six months follow‐up, the authors reported a significant improvement in adherence to iron chelator therapy, in serum ferritin as a marker of iron overload, in participants' satisfaction and in quality of life, with fewer drug‐related problems in the intervention arm compared to the control arm (<a href="./references#CD012900-bbs2-0033" title="BahnasawySM , ElWakeelLM , BeblawyNE , El‐HamamsyM . Clinical pharmacist‐provided services In iron‐overloaded beta‐thalassaemia major children: a new insight Into patient care. Basic Clinical &amp; Pharmacology &amp; Toxicology2017;120(4):354‐9. ">Bahnasawy 2017</a>). </p> <p>Pakpaz examined the impact of providing patient education about iron overload with assessment of adherence to iron chelation therapy (subcutaneous deferoxamine injections) using the numerical Likert Scale and liver iron concentration or overload status using SQUID biosusceptometer (<a href="./references#CD012900-bbs2-0064" title="PakbazZ , FischerR , TreadwellM , YamashitaR , FungEB , CalvelliL , et al. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Annals of the New York Academy of Sciences2005;1054:486‐91. ">Pakbaz 2005</a>). The authors showed improvement in self‐report adherence rates to iron chelation therapy as well as liver iron concentration at 15 months follow‐up (<a href="./references#CD012900-bbs2-0064" title="PakbazZ , FischerR , TreadwellM , YamashitaR , FungEB , CalvelliL , et al. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Annals of the New York Academy of Sciences2005;1054:486‐91. ">Pakbaz 2005</a>). </p> <p>Koch evaluated the effect of contingency contracting with 23 people with β‐thalassemia as an intervention to improve their adherence level to iron chelation therapy (subcutaneous deferoxamine injections) and measured adherence by counting the number of empty vials (<a href="./references#CD012900-bbs2-0055" title="KochDA , GiardinaPJ , RyanM , MacQueenM , HilgartnerMW . Behavioral contracting to improve adherence in patients with thalassemia. Journal of Pediatric Nursing1993;8(2):106‐11. ">Koch 1993</a>). At six months follow‐up, the authors reported success of the contingency contracting program with improvement in adherence rates in majority of participants. </p> <p>Treadwell examined the impact of participating in Desferal or Deferoxamine Day Camp with educational strategies and peer support as an intervention to improve self‐management skills in 15 individuals with β‐thalassemia or sickle cell disease and their caregivers (<a href="./references#CD012900-bbs2-0085" title="TreadwellMJ , WeissmanL . Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. Seminars in Hematology2001;38(1 Suppl 1):77‐84. ">Treadwell 2001</a>). The authors showed adherence to iron chelation at follow‐up (i.e. number of days of deferoxamine administration) was associated with perceived level of support as well as patient and caregiver disease knowledge. The authors also reported that increased disease knowledge as well as shared responsibilities for care of home between patients and their caregivers have been associated with an improvement in markers of iron overload with lower serum ferritin and liver iron concentration (<a href="./references#CD012900-bbs2-0085" title="TreadwellMJ , WeissmanL . Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. Seminars in Hematology2001;38(1 Suppl 1):77‐84. ">Treadwell 2001</a>). </p> <p>Further, a recent Cochrane Review identified no published data on psychological therapies for people with thalassemia as interventions to improve their ability to cope and self‐manage their condition, or improve both medical and psychosocial outcomes (<a href="./references#CD012900-bbs2-0025" title="Anie , K.A , Massaglia . P . Psychological therapies for thalassaemia. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD002890.pub2] ">Anie 2014</a>). </p> <p>Another Cochrane Review showed very limited evidence to suggest indications that mobile phone messaging interventions may be beneficial in promoting self‐management in people with chronic illnesses (<a href="./references#CD012900-bbs2-0042" title="deJonghT , Gurol‐UrganciI , Vodopivec‐JamsekV , CarJ , AtunR . Mobile phone messaging for facilitating self‐management of long‐term illnesses. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD007459.pub2] ">de Jongh 2012</a>). Similarly, Badawy has systematically evaluated the effects of text messaging and mobile phone apps as interventions to improve adherence to preventive behavior and to chronic medication regimens in adolescents (<a href="./references#CD012900-bbs2-0029" title="BadawySM , KuhnsLM . Texting and mobile phone app interventions for improving adherence to preventive behavior in adolescents: a systematic review. JMIR Mhealth and Uhealth2017;5(4):e50. ">Badawy 2017a</a>; <a href="./references#CD012900-bbs2-0030" title="BadawySM , SinnoMG , KavianyS , O’DwyerL , KuhnsLM . Text messaging and smartphone app interventions to improve medication adherence in adolescents with chronic conditions: a systematic review. JMIR Mhealth and Uhealth2017;5(5):e66. ">Badawy 2017b</a>). The authors reported significant improvement in adherence with moderate effect sizes, although most of the included studies were of low or moderate quality (<a href="./references#CD012900-bbs2-0029" title="BadawySM , KuhnsLM . Texting and mobile phone app interventions for improving adherence to preventive behavior in adolescents: a systematic review. JMIR Mhealth and Uhealth2017;5(4):e50. ">Badawy 2017a</a>; <a href="./references#CD012900-bbs2-0030" title="BadawySM , SinnoMG , KavianyS , O’DwyerL , KuhnsLM . Text messaging and smartphone app interventions to improve medication adherence in adolescents with chronic conditions: a systematic review. JMIR Mhealth and Uhealth2017;5(5):e66. ">Badawy 2017b</a>). Furthermore, Thakkar conducted a meta‐analysis of RCTs to assess the effect of mobile phone text messaging interventions on medication adherence in chronic disease (<a href="./references#CD012900-bbs2-0081" title="ThakkarJ , KurupR , LabaTL , SantoK , ThiagalingamA , RodgersA , et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta‐analysis. JAMA Internal Medicine2016;176(3):340‐9. ">Thakkar 2016</a>). The authors found that these interventions increased the odds of medication adherence by approximately two‐fold, with about an 18% increase in adherence rates; however, most were of short duration and used self‐report measures of medication adherence (<a href="./references#CD012900-bbs2-0081" title="ThakkarJ , KurupR , LabaTL , SantoK , ThiagalingamA , RodgersA , et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta‐analysis. JAMA Internal Medicine2016;176(3):340‐9. ">Thakkar 2016</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012900-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/media/CDSR/CD012900/urn:x-wiley:14651858:media:CD012900:CD012900-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/media/CDSR/CD012900/image_t/tCD012900-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012900-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012900.pub2/media/CDSR/CD012900/image_n/nCD012900-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/full#CD012900-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012900.pub2/media/CDSR/CD012900/image_n/nCD012900-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012900.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012900-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012900-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012900-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012900-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD012900-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012900-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012900-note-0006">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012900-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012900\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012900\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012900\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012900\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012900\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012900.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012900.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012900.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012900.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012900.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720058313"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012900.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720058317"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012900.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df7e40ccb9368',t:'MTc0MDcyMDA1OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 